<DOC>
	<DOCNO>NCT01462370</DOCNO>
	<brief_summary>This study determine overall analgesic effect single oral dose etoricoxib compare ibuprofen participant moderate-to-severe primary dysmenorrhea .</brief_summary>
	<brief_title>Study Assess Safety Efficacy Etoricoxib Versus Ibuprofen Treatment Dysmenorrhea ( MK-0663-145 AM1 )</brief_title>
	<detailed_description>Participants meet study entry criterion randomly allocate 2 possible sequence 2 treatment regimen course 2 menstrual cycle . In treatment sequence 1 , participant receive etoricoxib 120 mg daily menstrual cycle 1 , ibuprofen 2400 mg/daily menstrual cycle 2 . In treatment sequence 2 , participant receive ibuprofen 2400 mg/daily menstrual cycle 1 etoricoxib 120 mg daily menstrual cycle 2 .</detailed_description>
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<criteria>Agree remain abstinent use doublebarrier contraception throughout study . Participants status post tubal ligation exempt requirement . Moderate severe primary dysmenorrhea minimum 4 previous 6 menstrual cycle . Moderate : Overthecounter analgesic provide significant relief menstrual cycle ; discomfort interfere usual activity . Severe : Overthecounter analgesic consistently effective , prescription analgesic require least menstrual cycle ; discomfort incapacitate cause inability work usual activity . Willing limit alcohol intake 2 drink equivalent per day duration study followup period well avoid exercise first 24 hour postdose menstrual cycle . Able read , understand , complete diary . Use intrauterine device . Pregnant , breast feeding , &lt; 6 week postpartum . Active gastric ulcer history inflammatory bowel disease . Uncontrolled hypertension . Uncontrolled diabetes mellitus renal disease . Class IIIV congestive heart failure . Coronary artery bypass graft surgery , angioplasty , myocardial infarction , cerebrovascular accident transient ischemic attack within past 6 month . Unstable angina . Mild , moderate , severe hepatic insufficiency . Any personal family history inherit acquire bleed disorder . History neoplastic disease ; Exceptions : 1 ) adequately treat basal cell carcinoma carcinoma situ cervix ; 2 ) malignancy successfully treat &gt; equal 5 year prior screen . Participants history leukemia , lymphoma , malignant melanoma , myeloproliferative disease ineligible study regardless time since treatment . Allergic etoricoxib , ibuprofen , acetaminophen , indomethacin , nonsteroidal antiinflammatory drug ( NSAIDs ) , cyclooxygenase ( COX ) 2 inhibitor , component Saridon ( propyphenazone/paracetamol/caffeine ) . Recent history chronic analgesic tranquilizer use dependence . Morbidly obese demonstrates significant health problem stem obesity . Current user recreational illicit drug recent history drug alcohol abuse dependence . Participated another clinical study within last 4 week . Not able swallow oral medication : surgical anatomical condition preclude swallow absorb oral medication ongoing basis .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>